81 Results

People

  1. Lacouture
    Lacouture
  2. Motzer
    Motzer
  3. Rogak
    Rogak
  4. Atkinson
    Atkinson
  5. Basch
    Basch
  6. Belum
    Belum
  7. Dusza
    Dusza
  8. Jackson
    Jackson
  9. Markova
    Markova
  10. Mauro
    Mauro

Groups

  1. Department of Medicine (48)
  2. Solid Tumor Oncology Division (28)
  3. Division of Subspecialty Medicine (19)
  4. Survivorship Research (18)
  5. Dermatology Service (13)
  6. Dermatology (13)
  7. Hematologic Malignancies, Division of (12)
  8. Center for Hematologic Malignancies (11)
  9. Epidemiology and Biostatistics (10)
  10. Genitourinary Oncology Service (10)
  1. "adverse events"
Formats
  1. Journal Article (60)
  2. Review (16)
  3. Book Section (3)
  4. Conference Paper (2)
Groups
  1. Department of Medicine (48)
  2. Solid Tumor Oncology Division (28)
  3. Division of Subspecialty Medicine (19)
  4. Survivorship Research (18)
  5. Dermatology (13)
  6. Dermatology Service (13)

More Groups

People
  1. Mario Lacouture (11)
  2. Lauren Rogak (5)
  3. Robert Motzer (5)
  4. Ethan Basch (4)
  5. Jedd Wolchok (4)
  6. Alina Markova (3)

More People

Years
  1. 2025 (3)
  2. 2024 (11)
  3. 2023 (5)
  4. 2022 (8)
  5. 2021 (3)
  6. 2020 (6)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (10)
  2. The Oncologist (4)
  3. Clinical Lymphoma, Myeloma and Leukemia (3)
  4. European Journal of Cancer (3)
  5. Anesthesia and Analgesia (2)
  6. Cancer (2)

More Publications

Publishers
  1. Elsevier Inc. (22)
  2. Oxford University Press (7)
  3. Lippincott Williams & Wilkins (6)
  4. Elsevier Science, Inc. (5)
  5. Demos Medical Publications (3)
  6. Sage Publications (3)

More Publishers

Results (81)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample
    Journal Article

    Mead-Harvey, C.; Basch, E.; Rogak, L. J.; Langlais, B. T.; Thanarajasingam, G.; Ginos, B. F.; Lee, M. K.; Yee, C.; Mitchell, S. A.; Minasian, L. M.; more...
    Clinical Trials (2025)

    Fulltext@MSK | Save
  • Novel cancer therapeutics: Perioperative implications and challenges
    Review

    Gutierrez, C.; Rajendram, P.; Idowu, O.
    Anesthesia and Analgesia (2025)

    Fulltext@MSK | Save
  • Safety observations in neuroblastoma patients undergoing (18)F- mFBG PET
    Journal Article

    Pandit-Taskar, N.; Basu, E.; Balquin, E.; Mozley, P. D.; Jacobson, A. F.; Modak, S.
    Nuclear Medicine Communications (2025)

    Fulltext@MSK | Save
  • Oral minoxidil for late alopecia in cancer survivors
    Journal Article

    Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K. F.; Pan, A.; Kraehenbuehl, L.; Dusza, S.; Gajria, D.; Lake, D. E.; Bromberg, J. F.; Traina, T. A.; more...
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Best patient care practices for administering PSMA-targeted radiopharmaceutical therapy
    Review

    Calais, J.; Morris, M. J.; Kendi, A. T.; Kalebasty, A. R.; Tutrone, R.; Anderson, M. J.; Sartor, O.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Symptom improvements and adverse effects with Reishi mushroom use: A cross-sectional survey of cancer patients
    Journal Article

    Li, X.; Sun, L.; Chimonas, S.; Li, S. Q.; Feng, P.; Yang, Y.; Mao, J. J.
    Integrative Medicine Research (2024)

    Fulltext@MSK | Save
  • Dermatologic adverse events associated with chimeric antigen receptor T-cell therapy: A pharmacovigilance analysis of the FDA Reporting System
    Journal Article

    Storgard, R.; Dusza, S.; Shouval, R.; Scordo, M.; Markova, A.
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials
    Journal Article

    Nicolò, E.; Gandini, S.; Giugliano, F.; Uliano, J.; D'Ecclesiis, O.; Morganti, S.; Ferraro, E.; Trapani, D.; Tarantino, P.; Zagami, P.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Consolidation osimertinib versus durvalumab versus observation after concurrent chemoradiation in unresectable EGFR-mutant NSCLC: A multicenter retrospective cohort study
    Journal Article

    Nassar, A. H.; Kim, S. Y.; Aredo, J. V.; Feng, J.; Shepherd, F.; Xu, C.; Kaldas, D.; Gray, J. E.; Dilling, T. J.; Neal, J. W.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Radiation dose-volume-response relationships for adverse events in childhood cancer survivors: Introduction to the scientific issues in PENTEC
    Review

    Bentzen, S. M.; Vogelius, I. R.; Hodgson, D.; Howell, R.; Jackson, A.; Hua, C. H.; Olch, A. J.; Ronckers, C.; Kremer, L.; Milano, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save